Back to Search Start Over

Hypothermic Oxygenated Machine Perfusion Reduces Early Allograft Injury and Improves Post-transplant Outcomes in Extended Criteria Donation Liver Transplantation From Donation After Brain Death

Authors :
Sandra Pavicevic
Zoltan Czigany
Dimitri A. Raptis
Ulf P. Neumann
Irinel Popescu
Isabella Lurje
Matej Kocik
Wen-Jia Liu
Rene Tolba
Florian W. R. Vondran
Cynthia Ju
Arianeb Mehrabi
Joachim Andrassy
Wenzel Schöning
Hannah Miller
Frank Tacke
Pavel Strnad
Georg Lurje
Deniz Uluk
Jiří Froněk
Johann Pratschke
Markus Guba
Christian Trautwein
Theresa Keller
Matthijs Kramer
MUMC+: MA Maag Darm Lever (9)
RS: FHML non-thematic output
Source :
Annals of Surgery, 274(5), 705-712. LIPPINCOTT WILLIAMS & WILKINS
Publication Year :
2021
Publisher :
LIPPINCOTT WILLIAMS & WILKINS, 2021.

Abstract

OBJECTIVE: The aim of this study was to evaluate peak serum alanine aminotransferase (ALT) and postoperative clinical outcomes after hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS) in extended criteria donation (ECD) liver transplantation (LT) from donation after brain death (DBD).BACKGROUND: HOPE might improve outcomes in LT, particularly in high-risk settings such as ECD organs after DBD, but this hypothesis has not yet been tested in a randomized controlled clinical trial (RCT).METHODS: Between September 2017 and September 2020, 46 patients undergoing ECD-DBD LT from four centers were randomly assigned to HOPE (n = 23) or SCS (n = 23). Peak-ALT levels within 7 days following LT constituted the primary endpoint. Secondary endpoints included incidence of postoperative complications [Clavien-Dindo classification (CD), Comprehensive Complication Index (CCI)], length of intensive care- (ICU) and hospital-stay, and incidence of early allograft dysfunction (EAD).RESULTS: Demographics were equally distributed between both groups [donor age: 72 (IQR: 59-78) years, recipient age: 62 (IQR: 55-65) years, labMELD: 15 (IQR: 9-25), 38 male and 8 female recipients]. HOPE resulted in a 47% decrease in serum peak ALT [418 (IQR: 221-828) vs 796 (IQR: 477-1195) IU/L, P = 0.030], a significant reduction in 90-day complications [44% vs 74% CD grade ≥3, P = 0.036; 32 (IQR: 12-56) vs 52 (IQR: 35-98) CCI, P = 0.021], and shorter ICU- and hospital-stays [5 (IQR: 4-8) vs 8 (IQR: 5-18) days, P = 0.045; 20 (IQR: 16-27) vs 36 (IQR: 23-62) days, P = 0.002] compared to SCS. A trend toward reduced EAD was observed for HOPE (17% vs 35%; P = 0.314).CONCLUSION: This multicenter RCT demonstrates that HOPE, in comparison to SCS, significantly reduces early allograft injury and improves post-transplant outcomes in ECD-DBD liver transplantation.

Details

Language :
English
ISSN :
15281140 and 00034932
Volume :
274
Issue :
5
Database :
OpenAIRE
Journal :
Annals of Surgery
Accession number :
edsair.doi.dedup.....cbb8f1c6bf7f07b8d3049efaf0f06972
Full Text :
https://doi.org/10.1097/SLA.0000000000005110